Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines

Stock Information for Applied DNA Sciences Inc

Loading

Please wait while we load your information from QuoteMedia.